• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Cigna Corporation (Amendment)

    2/14/23 1:32:59 PM ET
    $CI
    Medical Specialities
    Health Care
    Get the next $CI alert in real time by email
    SC 13G/A 1 d390295dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    SCHEDULE 13G

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (AMENDMENT NO. 1)*

     

     

    Cigna Corporation

    (Name of Issuer)

    Common Stock

    (Title of Class of Securities)

    125523100

    (CUSIP Number)

    December 31, 2022

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP NO. 125523100    13G    PAGE 2 OF 4 PAGES

     

      1   

    NAME OF REPORTING PERSON

    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     

    Dodge & Cox    94-1441976

      2   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  ☐        (b)  ☐

     

    N/A

      3   

    SEC USE ONLY

     

      4   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    California - U.S.A.

    NUMBER OF

    SHARES

     BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

          5     

    SOLE VOTING POWER

     

    10,925,157

          6     

    SHARED VOTING POWER

     

    0

          7     

    SOLE DISPOSITIVE POWER

     

    11,548,557

          8   

    SHARED DISPOSITIVE POWER

     

    0

    9   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    11,548,557

    10   

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

    N/A

    11   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    3.8%

    12   

    TYPE OF REPORTING PERSON*

     

    IA


    Item 1(a)

    Name of Issuer:

    Cigna Corporation

     

    Item 1(b)

    Address of Issuer’s Principal Executive Offices:

    900 Cottage Grove Road

    Bloomfield, Connecticut 06002

     

    Item 2(a)

    Name of Person Filing:

    Dodge & Cox

     

    Item 2(b)

    Address of the Principal Office or, if none, Residence:

    555 California Street, 40th Floor

    San Francisco, CA 94104

     

    Item 2(c)

    Citizenship:

    California - U.S.A.

     

    Item 2(d)

    Title of Class of Securities:

    Common Stock

     

    Item 2(e)

    CUSIP Number:

    125523100

     

    Item 3

    If the Statement is being filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a:

    (e) ☒ Investment Advisor registered under section 203 of the Investment Advisors Act of 1940

     

    Item 4

    Ownership:

     

      (a)

    Amount Beneficially Owned:

    11,548,557

     

      (b)

    Percent of Class:

    3.8%


      (c)

    Number of shares as to which such person has:

     

      (i)

    sole power to vote or direct the vote:

    10,925,157

     

      (ii)

    shared power to vote or direct the vote:

    0

     

      (iii)

    sole power to dispose or to direct the disposition of:

    11,548,557

     

      (iv)

    shared power to dispose or to direct the disposition of:

    0

     

    Item 5

    Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☒.

     

    Item 6

    Ownership of More than Five Percent on Behalf of Another Person:

    Not applicable.

     

    Item 7

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company:

    Not applicable.

     

    Item 8

    Identification and Classification of Members of the Group:

    Not applicable.

     

    Item 9

    Notice of Dissolution of a Group:

    Not applicable.

     

    Item 10

    Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect.

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: February 14, 2023

     

    DODGE & COX
    By:  

    /S/ Katherine M. Primas

    Name:   Katherine M. Primas
    Title:   Chief Compliance Officer
    Get the next $CI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CI

    DatePrice TargetRatingAnalyst
    2/6/2025$323.00Outperform → Mkt Perform
    Bernstein
    6/26/2024$400.00Overweight
    Piper Sandler
    5/30/2024$388.00Outperform
    Robert W. Baird
    3/6/2024$393.00Overweight
    Barclays
    2/5/2024$334.00 → $372.00Neutral → Overweight
    Cantor Fitzgerald
    2/5/2024$327.00 → $354.00Sector Perform → Outperform
    RBC Capital Mkts
    2/1/2024$355.00 → $370.00Hold → Buy
    Deutsche Bank
    1/4/2024$330.00 → $372.00Mkt Perform → Outperform
    Bernstein
    More analyst ratings

    $CI
    SEC Filings

    See more
    • SEC Form 144 filed by The Cigna Group

      144 - Cigna Group (0001739940) (Subject)

      5/8/25 4:11:59 PM ET
      $CI
      Medical Specialities
      Health Care
    • SEC Form 144 filed by The Cigna Group

      144 - Cigna Group (0001739940) (Subject)

      5/7/25 5:13:55 PM ET
      $CI
      Medical Specialities
      Health Care
    • SEC Form 144 filed by The Cigna Group

      144 - Cigna Group (0001739940) (Subject)

      5/6/25 4:47:00 PM ET
      $CI
      Medical Specialities
      Health Care

    $CI
    Financials

    Live finance-specific insights

    See more
    • The Cigna Group Reports Strong First Quarter 2025 Results, Raises 2025 Outlook

      Total revenues for the first quarter 2025 increased 14% to $65.5 billionShareholders' net income for the first quarter 2025 was $1.3 billion, or $4.85 per shareAdjusted income from operations1 for the first quarter 2025 was $1.8 billion, or $6.74 per share2025 adjusted income from operations1,2 increased to at least $29.60 per share2BLOOMFIELD, Conn., May 2, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported strong first quarter 2025 results, reflecting growth and focused execution across its diversified portfolio of businesses. "We are buildin

      5/2/25 6:00:00 AM ET
      $CI
      Medical Specialities
      Health Care
    • The Cigna Group Declares Quarterly Dividend

      BLOOMFIELD, Conn., April 23, 2025 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE:CI) today declared a cash dividend of $1.51 per share of its common stock, payable on June 18, 2025 to shareholders of record as of the close of business on June 3, 2025. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services m

      4/23/25 4:30:00 PM ET
      $CI
      Medical Specialities
      Health Care
    • AM Best Affirms Credit Ratings of The Cigna Group and Its Subsidiaries

      AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of "a+" (Excellent) of the key U.S. life/health subsidiaries and Europe-based insurance companies of The Cigna Group (Cigna) (headquartered in Bloomfield, CT) (NYSE:CI). In addition, AM Best has affirmed the Long-Term ICR of "bbb+" (Good) and the Long-Term Issue Credit Ratings (Long-Term IRs) of Cigna. AM Best also has affirmed the Short-Term Issue Credit Rating (Short-Term IR) of Cigna. The outlook of these Credit Ratings (ratings) is stable. (Please see below for a detailed listing of the companies and ratings.) The majority of Cigna's core U.S. health insuran

      4/8/25 5:46:00 PM ET
      $CI
      Medical Specialities
      Health Care

    $CI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • The Cigna Group Reports Strong First Quarter 2025 Results, Raises 2025 Outlook

      Total revenues for the first quarter 2025 increased 14% to $65.5 billionShareholders' net income for the first quarter 2025 was $1.3 billion, or $4.85 per shareAdjusted income from operations1 for the first quarter 2025 was $1.8 billion, or $6.74 per share2025 adjusted income from operations1,2 increased to at least $29.60 per share2BLOOMFIELD, Conn., May 2, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported strong first quarter 2025 results, reflecting growth and focused execution across its diversified portfolio of businesses. "We are buildin

      5/2/25 6:00:00 AM ET
      $CI
      Medical Specialities
      Health Care
    • The Cigna Group Declares Quarterly Dividend

      BLOOMFIELD, Conn., April 23, 2025 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE:CI) today declared a cash dividend of $1.51 per share of its common stock, payable on June 18, 2025 to shareholders of record as of the close of business on June 3, 2025. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services m

      4/23/25 4:30:00 PM ET
      $CI
      Medical Specialities
      Health Care
    • The Cigna Group Foundation Commits Additional $1M to Boys & Girls Clubs of America to Support Youth Mental Health

      BLOOMFIELD, Conn., April 22, 2025 /PRNewswire/ -- As part of The Cigna Group's (NYSE:CI) multiyear commitment to improve youth mental health, The Cigna Group Foundation announced a $1 million contribution over the next two years to Boys & Girls Clubs of America. Boys & Girls Clubs of America will use the funding to expand its work with local Clubs to train staff on how to identify the signs and symptoms of youth in distress, and become trauma-informed in their policies, practices, and programs, and expand the use of its successful Behavioral Support Toolkit to all Clubs. "As a

      4/22/25 10:00:00 AM ET
      $CI
      Medical Specialities
      Health Care

    $CI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Wiseman Eric C was granted 638 shares, increasing direct ownership by 3% to 23,158 units (SEC Form 4)

      4 - Cigna Group (0001739940) (Issuer)

      4/25/25 4:33:03 PM ET
      $CI
      Medical Specialities
      Health Care
    • Director Ross Kimberly A. was granted 638 shares, increasing direct ownership by 16% to 4,512 units (SEC Form 4)

      4 - Cigna Group (0001739940) (Issuer)

      4/25/25 4:33:00 PM ET
      $CI
      Medical Specialities
      Health Care
    • Director Zarcone Donna F was granted 638 shares, increasing direct ownership by 2% to 26,735 units (SEC Form 4)

      4 - Cigna Group (0001739940) (Issuer)

      4/25/25 4:33:04 PM ET
      $CI
      Medical Specialities
      Health Care

    $CI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by The Cigna Group

      SC 13G - Cigna Group (0001739940) (Subject)

      11/12/24 9:55:14 AM ET
      $CI
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by The Cigna Group (Amendment)

      SC 13G/A - Cigna Group (0001739940) (Subject)

      2/13/24 5:02:29 PM ET
      $CI
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by The Cigna Group (Amendment)

      SC 13G/A - Cigna Group (0001739940) (Subject)

      2/9/24 8:50:20 AM ET
      $CI
      Medical Specialities
      Health Care

    $CI
    Leadership Updates

    Live Leadership Updates

    See more
    • The Cigna Group's "Community Vitality Project" Donates $75,000 to Nonprofits through Program Encouraging Fitness and Community Engagement

      As part of the company's initiative, thousands of employees logged 280,000 minutes of exercise over nine days Cigna leaders biked to Hartford, Conn.'s Dunkin' Park to host Boys & Girls Clubs members for a Yard Goats baseball game, with surprise appearances by UConn basketball coach and playersBLOOMFIELD, Conn., Sept. 9, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI) put out a challenge to its workforce this summer, inviting colleagues to join its first-ever Community Vitality Project, a nine-day challenge combining fun, fitness and fundraising. By logging more than 280,000 minutes of fitness activities and awarding their minutes spent moving, The Cigna Group employees helped determine how to

      9/9/24 7:00:00 AM ET
      $CI
      Medical Specialities
      Health Care
    • The Cigna Group announces leadership changes to continue driving growth

      Brian Evanko to continue as Chief Financial Officer, will serve as new President and CEO of Cigna HealthcareAnn Dennison to join The Cigna Group as Deputy Chief Financial OfficerMike Triplett to retire by end of 2024 and Bryan Holgerson promoted to President of U.S. Commercial for Cigna HealthcareEric Palmer to assume expanded role leading enterprise strategy and corporate development, will continue as President and CEO of Evernorth Health ServicesBLOOMFIELD, Conn., Jan. 17, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI), a global health company, today announced leadership changes designed to continue accelerating growth across Evernorth Health Services and Cigna Healthcare.

      1/17/24 9:15:00 AM ET
      $CI
      Medical Specialities
      Health Care
    • The Cigna Group Announces Appointment of Dr. Philip Ozuah to Board of Directors

      BLOOMFIELD, Conn., May 1, 2023 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today announced that Dr. Philip Ozuah has been appointed to the organization's Board of Directors. His appointment is effective June 1, 2023. CI) today announced that Dr. Philip Ozuah has been appointed to the organization's Board of Directors. His appointment is effective June 1, 2023." alt="The Cigna Group (NYSE:CI) today announced that Dr. Philip Ozuah has been appointed to the organization's Board of Directors. His appointment is effective June 1, 2023."> Since 2019, Dr. Philip Oz

      5/1/23 6:00:00 AM ET
      $CI
      Medical Specialities
      Health Care

    $CI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • The Cigna Group downgraded by Bernstein with a new price target

      Bernstein downgraded The Cigna Group from Outperform to Mkt Perform and set a new price target of $323.00

      2/6/25 7:05:01 AM ET
      $CI
      Medical Specialities
      Health Care
    • Piper Sandler initiated coverage on The Cigna Group with a new price target

      Piper Sandler initiated coverage of The Cigna Group with a rating of Overweight and set a new price target of $400.00

      6/26/24 7:28:18 AM ET
      $CI
      Medical Specialities
      Health Care
    • Robert W. Baird initiated coverage on The Cigna Group with a new price target

      Robert W. Baird initiated coverage of The Cigna Group with a rating of Outperform and set a new price target of $388.00

      5/30/24 7:35:19 AM ET
      $CI
      Medical Specialities
      Health Care